Advanced Finance

Significant Risk Transfer Trades

A bank keeps its loans, sells the middle slice of their credit risk to a fund, and gets a large chunk of its regulatory capital back. Learn the arithmetic, the conditions a regulator imposes, and the argument about whether the risk really left.

  • Expert
  • 13 min total
  • 13 chapters

What decision this helps you make: Whether a synthetic risk transfer is worth doing - which turns on the premium paid, the capital actually released, and whether the bank is constrained by risk-weighted capital in the first place.

What this topic is

A significant risk transfer trade, usually called an SRT, is a synthetic securitisation of a bank's own loan book. The bank keeps the loans on its balance sheet and continues to service the relationships. It buys credit protection on a tranche of the portfolio - typically a mezzanine slice sitting above a thin retained first loss - usually funded by credit-linked notes with cash collateral, sometimes unfunded through a guarantee. If the supervisor accepts that significant risk has genuinely been transferred, the bank may reduce the risk-weighted assets it holds against the portfolio, and therefore the capital it must fund.

Why it matters

For a bank constrained by risk-based capital, an SRT is one of the few ways to free capital without selling the assets, damaging the customer relationship, or raising equity. For an investor, it offers exposure to a diversified pool of bank-originated corporate or consumer credit that is otherwise unobtainable, at yields in the high single to low double digits. For a supervisor, it raises a hard question: has the risk actually gone somewhere else, or has it moved into a lightly regulated corner of the system and possibly back again through the financing chain?

Who should learn it

Bank treasury and capital management teams, credit investors evaluating protection tranches, structured finance lawyers and practitioners, and regulators or policy analysts assessing where credit risk in the banking system now sits.

What you will understand

  • How the capital relief arithmetic works, from portfolio risk weight to released capital, with a worked stylised example
  • The regulatory conditions that determine whether relief is recognised, and how they differ between Europe and the United States
  • How the premium is priced against expected loss, and why the economics of a real deal are tighter than they look
  • The genuine open questions: excess spread, circular financing, concentration among protection sellers, and pro-cyclicality

Prerequisites

Common misconception

The usual objection to SRT is that it is regulatory arbitrage - the risk stays with the bank and only the capital treatment changes. That is too simple in both directions. Where protection is fully cash collateralised through credit-linked notes, the bank genuinely holds cash against losses on the protected tranche and the transfer is real in any ordinary sense. The harder and more current question is different: if the funds selling protection finance their positions with leverage supplied by banks, the risk may have left one bank's capital calculation while remaining somewhere in the banking system through a different channel. That is the concern supervisors and the international bodies have actually raised, and as of writing it is unresolved rather than settled in either direction.